Home › Funds › STEMPOINT CAPITAL LP › AMLX

STEMPOINT CAPITAL LP position in AMLX

AMYLYX PHARMACEUTICALS INC · Health Care

STEMPOINT CAPITAL LP reported holding 384,304 shares of AMLX (AMYLYX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$6.9M, representing 1.53% of its reported portfolio and ranking #22 among its reported holdings. STEMPOINT CAPITAL LP has disclosed AMLX holdings in 5 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)384.30K sh
Reported value held$6.90M
Portfolio Weight1.53%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How STEMPOINT CAPITAL LP's AMLX position evolved

STEMPOINT CAPITAL LP first disclosed a stake in AMLX in Q4 2023 at 83,381 shares (US$1.2M). The position peaked in Q1 2026 at 669,685 shares, worth US$9.3M. Across 5 filings, STEMPOINT CAPITAL LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 384,304 shares valued at US$6.9M — a reduction of -285,381 shares quarter over quarter.. Notable position changes include a 104% increase in Q4 2025 (shares rose 15% over the following quarter), a 43% trim in Q2 2026 (shares rose 62% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 83.38K $1.23M New
Q3 2025 276.88K $3.76M New
Q4 2025 565.14K $6.83M Add
Q1 2026 669.68K $9.31M Add
Q2 2026 384.30K $6.90M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMLX and 13F data

AMLX (AMYLYX PHARMACEUTICALS INC) is a Health Care company. 50 other funds we track also report a position in AMLX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$149.7M), TCG Crossover Management, LLC (US$112.1M), Commodore Capital LP (US$101.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMLX

All AMLX fund holders →

FAQ

How long has STEMPOINT CAPITAL LP held AMLX?

STEMPOINT CAPITAL LP has disclosed AMLX holdings in 5 of the last 11 reported quarters, going back to Q4 2023.

What is STEMPOINT CAPITAL LP's current position in AMLX?

As of Q2 2026, STEMPOINT CAPITAL LP holds 384.30K shares of AMLX (AMYLYX PHARMACEUTICALS INC), valued at $6.90M, representing 1.53% of its reported portfolio and ranking #22.

Has STEMPOINT CAPITAL LP been buying or selling AMLX?

In the latest 13F filing (Q2 2026), STEMPOINT CAPITAL LP reduced its position in AMLX. The position peaked in Q1 2026 at 669.68K shares.

Which other funds hold AMLX?

Other major institutional holders of AMLX include PERCEPTIVE ADVISORS LLC, TCG Crossover Management, LLC, Commodore Capital LP, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.